An Untapped Resource: Pharmacists’ Role in Improving Screening and Management of NVAF

In this microlearning module, an expert faculty provides an overview of the prevalence, burden, and consequences of undiagnosed NVAF.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 12, 2022 Expired: April 11, 2023

In this microlearning module, an expert faculty provides insight on screening for NVAF in pharmacy settings.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 12, 2022 Expired: April 11, 2023

In this microlearning module, an expert faculty provides evidence-based recommendations on the use of DOAC therapy in NVAF for stroke prevention.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 13, 2022 Expired: April 12, 2023

In this microlearning module, an expert faculty discusses best practices in engaging patients and the healthcare team in collaborative, shared-decision making.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 12, 2022 Expired: April 11, 2023

Download these slides from a live webinar for expert faculty input on the burden of and screening methods for undiagnosed NVAF.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 13, 2022

Download these slides from a live webinar for expert faculty input on evidence-based recommendations on the use of DOAC therapy in NVAF for stroke prevention.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 13, 2022

Download these slides from a live webinar for expert faculty insights on best practices in engaging patients and the healthcare team in collaborative, shared decision-making.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 13, 2022

Cardiology pharmacists’ perspectives on the pharmacist’s role in screening for NVAF, access to DOAC therapies, and dosing nuances.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 13, 2022

An easy-to-follow, step-by-step infographic for the screening and management of NVAF.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 13, 2022

In this podcast, expert cardiology pharmacists Dr Kathleen Lusk and Dr Stephanie Dwyer Kaluzna discuss the prevalence, burden, and consequences of undiagnosed NVAF. They will explore evidence-based methods for NVAF screening and provide strategies to incorporate these within various pharmacy settings.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 25, 2022

In this podcast, expert cardiology pharmacist Dr Stephanie Dwyer Kaluzna discusses evidence-based recommendations on the use of DOAC therapy in NVAF for stroke prevention.

Stephanie Dwyer Kaluzna, PharmD, BCCP Released: April 25, 2022

In this podcast, expert cardiology pharmacist Dr Kathleen Lusk provides insights on best practices for engaging patients and the healthcare team in collaborative, shared decision-making for management of NVAF.

Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 26, 2022